Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Targovax Announces Completed Enrollment of ONCOS-102 Trial in Mesothelioma

prnewswireMay 08, 2019

Tag: Biotechnology , Solid Tumors , chemotherapy

PharmaSources Customer Service